{' '} {' '}
Limited time offer
SAVE % on your upgrade.

Page 8

InCharge HEALTHCARE 2020 actual knowledge a biologic therapy of medication used to boost a and treatment patient’s immune effects. Treatment system to fight the adjustments can be cancer cells. One of made in real-time the most exciting leading to better immunotherapies patient care . . . and is Cart-T. In Cart-T, not to have to sit in a immune cells are waiting room waiting. removed from the Healthcare to our patient and lab rural communities modified to better will improve as attack the cancer we expand our then put back in the telemedicine patient.” capabilities avoiding the patients’ need Looking Ahead: to drive an hour “Value-based to their closest healthcare is just provider. Payment getting started. As a reform . . . what country, we continue may on first glance to see healthcare seem disruptive, is spend move closer Mitch Graves actually going to be to 20 percent of GDP a significant relief to and our outcomes Title: Chief Executive Officer, West Cancer Center the entire provider are not improving. Birthplace: Memphis, Tennessee community. Employers, Medicare, Experience: Chief Executive Officer, West Cancer Center, May 2019 “In its formation, and patients to Present; President & CEO, Healthchoice, LLC 2013-2019; PresiMedicare created will continue to dent & CEO, Affiliated Services, Methodist Le Bonheur Healthcare payment siloes demand change that inadvertently that pays for results. led to significant The healthcare barriers to patients’ movement community is just now the ACA, fully covered preventive about the system of care. For understanding how social screenings helped reduce health example, it limited the visits to determinants play into a population disparities in communities such as your physician, required prior health so I expect more attention in Memphis. Another is the passage authorization for tests, restricted the coming years. of MACRA which has been the the criteria for admission to the “Technology will be a key factor driver to value-based healthcare hospital, and slowed the process in the coming decade. There are including bundled payments, ACOs, of accessing nursing home or new cancer diagnosis tools under medical homes, and for oncology, rehabilitation services after hospital development such as liquid (blood) Medicare’s Oncology Care Model discharge. Commercial insurance biopsies and breathalyzers which (OCM). soon followed in its managed care can identify presence of cancer “Value-based has started programs. Advanced Payment cells. I expect other vaccinations to tie quality metric, outcome Models are removing these such as the HPV vaccination to be measures, and patient satisfaction restrictions to patient movement developed in the future. Artificial to payments. Providers, especially . . . the details go beyond this Intelligence will have an impact hospitals, will need to shift from discussion, but the end result is that on radiology, lab, and research in volume to value, focusing to keep the patient, family, and provider will the next decade as data learning patients healthy. The shift to EMRs be the key decision makers, and improves. Specialty drug cost will over the last decade has allowed not necessarily the payer of the continue to be a topic of debate as data collection to measure quality, services.” the cost continues to grow at 10% utilization, and cost which was a year. missing the first time managed care Mitch Graves “In 2021, Medicare is moving was rolled out. Reflections: to a new oncology value-based “Oncology has probably seen “As an industry, there have been the most changes impacting patient model, Oncology Care First many significant changes impacting (OCF). Medicare’s aim is to care than any other specialty. To access, technology, reimbursement, enhance success of its current start, improved molecular testing and quality. No doubt the ACA Oncology Care Model with is changing how patients are had a major impact to the provider accountability for quality, treated. Molecular results provide healthcare landscape, providing outcomes and total cost of care. an opportunity for an individualized affordable coverage and access to Having been part of Medicare’s approach to disease treatment. a population that previously could OCM, West is well positioned for New treatments are now available not afford healthcare. Also under success in OCF.” such as immunotherapy which is

8 Memphis Medical News

Profile for Medical News

2020 Memphis Medical News InCharge Healthcare  

A Snapshot of Who’s Leading Memphis Healthcare Into the Next Decade

2020 Memphis Medical News InCharge Healthcare  

A Snapshot of Who’s Leading Memphis Healthcare Into the Next Decade